| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |